
Viatris Inc — Investor Relations & Filings
Viatris Inc. is a global healthcare company focused on empowering people to live healthier at every stage of life. The company operates by bridging the divide between generic and branded medicines, combining aspects of both to enhance patient access worldwide. Its portfolio comprises a wide range of high-quality medicines, including oral solid doses, injectables, complex dosage forms, and active pharmaceutical ingredients (APIs). These products cover numerous therapeutic areas, addressing both noncommunicable and infectious diseases. Viatris's offerings treat many of the World Health Organization's leading causes of death. The company continues to expand its capabilities, including recent acquisitions to strengthen its presence in the central nervous system (CNS) therapeutic area.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-15 | English | |
| 10-Q - Viatris Inc (0001792044) (Filer) | 2026-05-07 | English | |
| 8-K - Viatris Inc (0001792044) (Filer) | 2026-05-07 | English | |
| 8-K - Viatris Inc (0001792044) (Filer) | 2026-05-04 | English | |
| ARS - Viatris Inc (0001792044) (Filer) | 2026-04-02 | English | |
| SCHEDULE 13G/A - Viatris Inc (0001792044) (Subject) | 2026-03-27 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 46362392 | 8-K | 2026-05-15 | English | ||
| 43482070 | 10-Q - Viatris Inc (0001792044) (Filer) | 2026-05-07 | English | ||
| 42895498 | 8-K - Viatris Inc (0001792044) (Filer) | 2026-05-07 | English | ||
| 41052998 | 8-K - Viatris Inc (0001792044) (Filer) | 2026-05-04 | English | ||
| 33193496 | ARS - Viatris Inc (0001792044) (Filer) | 2026-04-02 | English | ||
| 33064241 | SCHEDULE 13G/A - Viatris Inc (0001792044) (Subject) | 2026-03-27 | English | ||
| 33035658 | 4 - Viatris Inc (0001792044) (Issuer) | 2026-03-24 | English | ||
| 33016417 | 144 - Viatris Inc (0001792044) (Subject) | 2026-03-23 | English | ||
| 32898342 | 10-K - VIATRIS INC (0001792044) (Filer) | 2026-02-26 | English | ||
| 32898341 | 8-K - VIATRIS INC (0001792044) (Filer) | 2026-02-26 | English | ||
| 31734391 | 3 Filing | 2026-02-13 | English | ||
| 31734323 | SCHEDULE 13G/A Filing | 2026-02-04 | English | ||
| 31734410 | 8-K Filing | 2026-02-03 | English | ||
| 13212628 | FORM 4 | 2026-01-02 | English | ||
|
2025
1 filing
| |||||
| 13212624 | 8-K | 2025-12-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Amylyx Pharmaceuticals, Inc.
Develops therapies for neurodegenerative diseases and other…
|
AMLX | US | Manufacturing |
|
AN2 Therapeutics, Inc.
Biopharmaceutical firm developing boron-based drugs for inf…
|
ANTX | US | Manufacturing |
|
Ananda Pharma Plc
Biopharmaceutical firm developing cannabinoid-based medicin…
|
ANAN | GB | Manufacturing |
|
ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.
Designs, develops, and manufactures molecular diagnostic so…
|
ANGEN | TR | Manufacturing |
|
ANAVEX LIFE SCIENCES CORP.
Clinical-stage biopharmaceutical company developing therape…
|
AVXL | US | Manufacturing |
|
Anbio Biotechnology
Develops and provides in-vitro diagnostic (IVD) solutions a…
|
NNNN | KY | Manufacturing |
|
Anebulo Pharmaceuticals, Inc.
Clinical-stage biotech developing therapies for acute canna…
|
ANEB | US | Manufacturing |
|
AnGes, Inc.
Biopharmaceutical firm developing gene-based and nucleotide…
|
4563 | JP | Manufacturing |
|
ANG Lifesciences India Limited
Develops and manufactures sterile dry powder and liquid inj…
|
540694 | IN | Manufacturing |
|
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD.
Develops biopharmaceuticals, genetic engineering products, …
|
300009 | CN | Manufacturing |
Viatris Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30502/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30502 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30502 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30502 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30502}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Viatris Inc (id: 30502)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.